# Montelukast

NDC: 71610-563
Generic name: Montelukast
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210211

FDA application: ANDA202843

## Active ingredients

- MONTELUKAST SODIUM: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-563"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-563
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fe3c0d4-94ff-43ca-9d24-54676fe593fe